Biochemical aspects of hormonal contraception: Effects on bone metabolism

European Journal of Contraception and Reproductive Health Care

Volumn 2, Issue 2, 1997, Pages 123-126

  Volpe, A ^a   Amram, A ^a   Cagnacci, A ^a   Battaglia, C ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Biochemical markers; Bone metabolism; Hormonal contraception; Osteoporosis

Indexed keywords

ALKALINE PHOSPHATASE; CREATININE; DESOGESTREL; ESTRADIOL; ESTRADIOL DERIVATIVE; ETHINYLESTRADIOL; FOLLITROPIN; HYDROXYPROLINE; ORAL CONTRACEPTIVE AGENT; OSTEOCALCIN; PROGESTERONE DERIVATIVE;

ARTICLE; BLOOD; BONE DENSITY; BONE REMODELING; CLINICAL TRIAL; DRUG EFFECT; FEMALE; HUMAN; MENOPAUSE; MIDDLE AGED; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; URINE;

ALKALINE PHOSPHATASE; BONE DENSITY; BONE REMODELING; CONTRACEPTIVES, ORAL, COMBINED; CONTRACEPTIVES, ORAL, HORMONAL; CREATININE; DESOGESTREL; ESTRADIOL; ESTRADIOL CONGENERS; ETHINYL ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; HYDROXYPROLINE; MENOPAUSE; MIDDLE AGED; OSTEOCALCIN; PROGESTERONE CONGENERS;

EID: 0031151219     PISSN: 13625187     EISSN: None     Source Type: Journal    
DOI: 10.3109/13625189709167466     Document Type: Article

References (15)

1. Louis O, Devroey P, Kalender W, Osteaux M. Bone loss in young hypoestrogenic women due to primary ovarian failure: spinal quantitative computed tomography. Fertil Steril 1989; 52: 227-31
2. Lloyd T, Buchanan JR, Ursino GR, Myers C, Woodward G, Halbert DR. Long-term oral contraceptive use does not affect trabecular bone density. Am J Obstet Gynecol 1989; 160: 402-4
3. Stevenson JC, Lees B, Devenport M, Cust MP, Ganger KF. Determinant of bone density in normal women: risk factors for future osteoporosis? Br Med J 1989; 298: 924-8
4. Biller BMK, Coughlin JF, Saxe V, Schoenfeld D, Spratt DI, Klibanski A. Osteopenia in women with hypothalamic amenorrhea: a prospective study. Obstet Gynecol 1991; 78: 996-1001
5. Komm BS, Terpening CM, Benz DJ. Estrogen binding receptors mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science 1988; 241: 81-4
6. Erikson EF, Colvard DS, Berg NJ. Evidence of estrogen receptors in normal human osteoblast-like cells. Science 1988; 241: 84-6
7. Stephen L, Corson MD. Oral contraceptives for the prevention of osteoporosis. J Reprod Med 1988; 38: 1015-20
8. Volpe A. The effect of the pill on bone metabolism. Proceedings of the 3rd Congress of the ESC, Athens 1994; 78-80
9. Newman RE, Loyan MA. The determination of hydroxyproline. J Biol Chem 1950; 84: 299-303
10. Christiansen C, Riis BJ. 17β-Estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women. J Clin Endocrinol Metab 1990; 71: 836-41
11. Goldsmith NF, Johnston JO. Bone mineral effects of oral contraceptive, pregnancy and lactation. J Bone Joint Surg 1975; 57A: 657
12. Lindsay R, Tohme J, Kanders B. The effects of oral contraceptive use on vertebral bone mass in pre- and postmenopausal women. Contraception 1986; 34: 333-40
13. Stevenson JC. Pathogenesis, prevention and treatment of osteoporosis. Obstet Gynecol 1990; 75: 36S-41S
14. Gambacciani M, Spinetti A, Taponeco F. Longitudinal evaluation of perimenopausal vertebral bone loss: effects of a low-dose oral contraceptive preparation on bone mineral density and metabolism. Obstet Gynecol 1994; 83: 392-6
15. Rodin A, Chapman M, Fogelman I. Bone density in users of combined oral contraception. Br J Fam Plann 1991; 16: 125